R.K. Gregory

Biologic Markers as Predictors of Clinical Outcome From Systemic Therapy for Primary Operable Breast Cancer

Jian Chang, T.J. Powles, D. Craig Allred et al. · Journal of Clinical Oncology · 1999 · 225 citations

Medicine, Oncology, Breast Oncology +15

Prediction of response to neoadjuvant chemoendocrine therapy in primary breast carcinomas.

Andreas Makris, T.J. Powles, Mitch Dowsett et al. · PubMed · 1997 · 146 citations

Medicine, Endocrinology, Oncology +15

The effect of tamoxifen and hormone replacement therapy on serum cholesterol, bone mineral density and coagulation factors in healthy postmenopausal women participating in a randomised, controlled tamoxifen prevention study

Jenny C. Chang, T.J. Powles, S. Ashley et al. · Annals of Oncology · 1996 · 116 citations · Full text

Medicine, Endocrinology, Gynecology +17

Prediction of clinical outcome from primary tamoxifen by expression of biologic markers in breast cancer patients.

Jenny C. Chang, T.J. Powles, D. Craig Allred et al. · PubMed · 2000 · 116 citations

Medicine, Oncology, Breast Oncology +16

Studies of the Potential Utility of Ki67 as a Predictive Molecular Marker of Clinical Response in Primary Breast Cancer

L. Assersohn, Janine Salter, T.J. Powles et al. · Breast Cancer Research and Treatment · 2003 · 69 citations

Medicine, Molecular Biology, Oncology +15